Hua Medicine AI Stock Analysis
Hua Medicine (HUMDF) AI Stock Analysis
Hua Medicine
(Other OTC:HUMDF)
No summary available
Hua Medicine (HUMDF) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $303.18M
- Dividend Yield
- ―
- Average Volume (3M)
- 2,000
- Price to Earnings (P/E)
- -18.1
- Beta (1Y)
- 0.10
- Revenue Growth
- 82.93%
- EPS Growth
- -110.17%
- Country
- US
- Employees
- 424
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Hua Medicine Business Overview & Revenue Model
Company Description
Hua Medicine (Shanghai) Ltd., a biopharmaceutical enterprise established in 2011 and headquartered in Beijing, China, specializes in the clinical development of novel therapeutic solutions, with a primary focus on addressing diabetes within the Chine...
Hua Medicine Peers Comparison
Overall Rating
HK:332079Outperform
HK:369274.5Outperform
HK:001373Outperform
HK:151369Neutral
HK:998956Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | HKD 27.61B | 5.86 | 7.92% | 5.45% | 7.94% | 52.83% | |
| 75Outperform | HKD 208.73B | 26.59 | 18.26% | 1.41% | 24.97% | 43.23% | |
| 73Outperform | HKD 20.31B | 160.39 | 1.43% | ― | -8.55% | -96.20% | |
| 69Neutral | HKD 29.40B | 18.10 | 11.32% | 6.22% | -9.56% | -23.22% | |
| 56Neutral | HKD 14.23B | 69.68 | 1.58% | 4.14% | -1.32% | -50.00% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HUMDF | Hua Medicine | 0.28 | -0.30 | -52.08% | |
| HK:0013 | HUTCHMED (China) Limited | 23.28 | -0.02 | -0.09% | |
| HK:1513 | Livzon Pharmaceutical Group Class H | 25.00 | -3.31 | -11.69% | |
| HK:3320 | China Resources Pharmaceutical Group Ltd. | 4.39 | -0.29 | -6.19% | |
| HK:9989 | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H | 4.01 | -1.34 | -24.97% | |
| HK:3692 | Hansoh Pharmaceutical Group Company Limited | 34.42 | -4.40 | -11.33% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
